Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial

Background: Long acting insulin detemir administered intranasally for three weeks enhanced memory for adults with Alzheimer’s disease dementia (AD) or amnestic mild cognitive impairment (MCI). The investigation of longer-term administration is necessary to determine whether benefits persist, whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Craft, Suzanne, Claxton, Amy, Baker, Laura D., Hanson, Angela J., Cholerton, Brenna, Trittschuh, Emily H., Dahl, Deborah, Caulder, Erin, Neth, Bryan, Montine, Thomas J., Jung, Youngkyoo, Maldjian, Joseph, Whitlow, Christopher, Friedman, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409050/
https://www.ncbi.nlm.nih.gov/pubmed/28372335
http://dx.doi.org/10.3233/JAD-161256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409050/
https://www.ncbi.nlm.nih.gov/pubmed/28372335
http://dx.doi.org/10.3233/JAD-161256

Ejemplares similares